Applied Health Economics and Health Policy

2004 - 2012

Edited by Tim Wrightson

from Springer Healthcare | Adis
Series data maintained by Dave Dustin ().

Access Statistics for this journal.
Track citations for all items by RSS feed
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 10, issue 3, 2012

Economic Evaluations of Adult Weight Management Interventions: A Systematic Literature Review Focusing on Methods Used for Determining Health Impacts pp. 145-162

Ulla Griffiths, Benedict Anigbogu and Kiran Nanchahal

Direct Healthcare Costs of Osteoporosis-Related Fractures in Managed Care Patients Receiving Pharmacological Osteoporosis Therapy pp. 163-173

Hema Viswanathan, Jeffrey Curtis, Jingbo Yu, Jeffrey White, Bradley Stolshek, Claire Merinar, Akhila Balasubramanian, Joel Kallich, John Adams and Sally Wade

Cost Effectiveness of Prostacyclins in Pulmonary Arterial Hypertension pp. 175-188

Antonio Roman, Joan Barberà, Pilar Escribano, Maria Sala, Laia Febrer, Itziar Oyaguez, Eliazar Sabater and Miguel Casado

National Health Insurance Reform in South Africa: Estimating the Implications for Demand for Private Health Insurance pp. 189-200

Okore Apia Okorafor

Cost-Effectiveness Analysis of Early versus Non-Early Intervention in Acute Migraine Based on Evidence from the 'Act when Mild' Study pp. 201-215

John Slof

Volume 10, issue 2, 2012

Using the Economics of Certification to Improve the Safety and Quality of Male Circumcision in Developing Countries: Three Models of Implementation pp. 77-85

Michael Richards

Evaluating the Epidemiology and Morbidity Burden Associated with Human Papillomavirus in Israel: Accounting for CIN1 and Genital Warts in Addition to CIN2/3 and Cervical Cancer pp. 87-97

Oren Shavit, Raanan Raz, Michal Stein, Gabriel Chodick, Eduardo Schejter, Yehuda Ben-David, Raanan Cohen, Daphna Arbel and Varda Shalev

Understanding Consumer Preferences in the Context of Managed Competition: Evidence from a Choice Experiment in Colombia pp. 99-111

Antonio Trujillo, Fernando Ruiz, John Bridges, Jeannette Amaya, Christine Buttorff and Angélica Quiroga

Insights from Triangulation of Two Purchase Choice Elicitation Methods to Predict Social Decision Making in Healthcare pp. 113-126

Jennifer Whitty, Sharyn Rundle-Thiele and Paul Scuffham

A Cost-Utility Analysis of Cinacalcet in Secondary Hyperparathyroidism in Five European Countries pp. 127-138

Sergio Iannazzo, Michela Carsi and Silvia Chiroli

Budget Impact Analysis of Switching to Darunavir/Ritonavir Monotherapy for HIV-Infected People in Spain pp. 139-141

Juan Pasquau, Joana Gostkorzewicz, Francisco Ledesma, Anne Anceau, Andrew Hill and Christiane Moecklinghoff

The Need for Measurement of Efficiency in Greek Primary Healthcare: The Case for Rural Southern and Western Greece pp. 143-144

Nikolaos Oikonomou, Yannis Tountas and John Kyriopoulos

Volume 10, issue 1, 2012

Triangulating Health Expenditure Estimates from Different Data Sources in Developing Countries: The Case of Pakistan's Private Health Expenditure pp. 1-13

Christian Lorenz

Intra-Operative vs Pre-Operative Endoscopic Sphincterotomy in Patients with Gallbladder and Common Bile Duct Stones: Cost-Utility and Value-of-Information Analysis pp. 15-29

Kurinchi Gurusamy, Edward Wilson, Andrew Burroughs and Brian Davidson

The Role of Health Economics in Alcohol Policy pp. 33-35

Christopher Doran and Joshua Byrnes

The Efficiency of a Volumetric Alcohol Tax in Australia pp. 37-49

Joshua Byrnes, Dennis James Petrie, Christopher Doran and Anthony Shakeshaft

Tackling Alcohol Misuse: Purchasing Patterns Affected by Minimum Pricing for Alcohol pp. 51-63

Anne Ludbrook, Dennis James Petrie, Lynda McKenzie and Shelley Farrar

Alcohol Policy and Taxation in South Africa: An Examination of the Economic Burden of Alcohol Tax pp. 65-76

John Ataguba

Volume 9, issue 6, 2011

Cost Effectiveness of Self-Monitoring of Blood Glucose (SMBG) for Patients with Type 2 Diabetes and Not on Insulin: Impact of Modelling Assumptions on Recent Canadian Findings pp. 351-365

Sandra Tunis

Early Retirement and Income Loss in Patients with Early and Advanced Parkinson's Disease pp. 367-376

Scott Johnson, Matthew Davis, Anna Kaltenboeck, Howard Birnbaum, ElizaBeth Grubb, Marcy Tarrants and Andrew Siderowf

Excess Costs Associated with Patients with Chronic Thromboembolic Pulmonary Hypertension in a US Privately Insured Population pp. 377-387

Noam Kirson, Howard Birnbaum, Jasmina Ivanova, Tracy Waldman, Vijay Joish and Todd Williamson

An Application of a Proposed Framework for Formulary Listing in Low-Income Countries: The Case of Côte d'Ivoire pp. 389-402

Vakaramoko Diaby and Jean Lachaine

A Review of the Cost Effectiveness of Bisphosphonates in the Treatment of Post-Menopausal Osteoporosis in Switzerland pp. 403-417

Kurt Lippuner, Richard Pollock, Jayne Smith-Palmer, Thomas Meury and William Valentine

Volume 9, issue 5, 2011

Nutrition Therapy Cost Analysis in the US: Pre-Mixed Multi-Chamber Bag vs Compounded Parenteral Nutrition pp. 281-292

Robin Turpin, Todd Canada, Frank Liu, Catherine Mercaldi, Alessandro Pontes-Arruda and Paul Wischmeyer

Excess Costs Associated with Patients with Pulmonary Arterial Hypertension in a US Privately Insured Population pp. 293-303

Noam Kirson, Howard Birnbaum, Jasmina Ivanova, Tracy Waldman, Vijay Joish and Todd Williamson

Cost Effectiveness of Chemoprevention for Prostate Cancer with Dutasteride in a High-Risk Population Based on Results from the REDUCE Clinical Trial pp. 305-315

Michael Kattan, Stephanie Earnshaw, Cheryl McDade, Libby Black and Gerald Andriole

Assessing Quality of Life among British Older People Using the ICEPOP CAPability (ICECAP-O) Measure pp. 317-329

Terry Flynn, Phil Chan, Joanna Coast and Tim Peters

Early Assessment of Medical Technologies to Inform Product Development and Market Access: A Review of Methods and Applications pp. 331-347

Maarten IJzerman and Lotte Steuten

Volume 9, issue 4, 2011

Design of Patient Access Schemes in the UK: Influence of Health Technology Assessment by the National Institute for Health and Clinical Excellence pp. 209-215

Jarosławski, Szymon and Mondher Toumi

Cost-Efficacy Analysis of the MONET Trial Using UK Antiretroviral Drug Prices pp. 217-223

Brian Gazzard, Andrew Hill and Anne Anceau

Ordering Errors, Objections and Invariance in Utility Survey Responses: A Framework for Understanding Who, Why and What to Do pp. 225-241

Eve Wittenberg and Lisa Prosser

The Use of Decision-Analytic Models in Parkinson's Disease: A Systematic Review and Critical Appraisal pp. 243-258

James Shearer, Colin Green, Carl Counsell and John Zajicek

Cost Effectiveness of Secondary vs Tertiary Prevention for Post-Menopausal Osteoporosis pp. 259-273

Dirk Mueller and Afschin Gandjour

Drugs for Rare Diseases: Influence of Orphan Designation Status on Price pp. 275-279

Eline Picavet, Marc Dooms, David Cassiman and Steven Simoens

Volume 9, issue 3, 2011

The Economics of the NHS Cancer Drugs Fund pp. 137-138

Alan Maynard and Karen Bloor

The Impact of Inclusion Criteria in Health Economic Assessments pp. 139-148

Anke Richter, Patricia Thieda, Kylie Thaler and Gerald Gartlehner

Valuing Health at Different Ages: Evidence from a Nationally Representative Survey in the US pp. 149-156

Daniel Eisenberg, Gary Freed, Matthew Davis, Dianne Singer and Lisa Prosser

Assessing the Performance of a New Generic Measure of Health-Related Quality of Life for Children and Refining it for Use in Health State Valuation pp. 157-169

Katherine Stevens

Patent Extension Policy for Paediatric Indications: An Evaluation of the Impact within Three Drug Classes in a State Medicaid Programme pp. 171-181

Richard Nelson, Carrie McAdam-Marx, Megan Evans, Robert Ward, Benjamin Campbell, Diana Brixner and Joanne Lafleur

Cost Effectiveness of Tobacco Control Policies in Vietnam: The Case of Population-Level Interventions pp. 183-196

Hideki Higashi, Khoa Truong, Jan Barendregt, Phuong Nguyen, Mai Vuong, Thuy Nguyen, Phuong Hoang, Angela Wallace, Tien Tran, Cuong Le and Christopher Doran

Hospital Costs, Length of Stay and Mortality Associated with Childhood, Adolescent and Young Adult Meningococcal Disease in the US pp. 197-207

Keith Davis, Timothy Bell, Jacqueline Miller, Derek Misurski and Bela Bapat

Volume 9, issue 2, 2011

Germany's Decision Rule for Setting Ceiling Prices of Drugs: A Comparative Analysis with Other Decision Rules pp. 65-71

Afschin Gandjour

Public and Decision Maker Stated Preferences for Pharmaceutical Subsidy Decisions: A Pilot Study pp. 73-79

Jennifer Whitty, Paul Scuffham and Sharyn Rundle-Thiele

Citizens' Preferences for Brand Name Drugs for Treating Acute and Chronic Conditions: A Pilot Study pp. 81-87

Arina Denoth, Christophe Pinget and Jean-Blaise Wasserfallen

Influenza Vaccination in Healthy Working Adults in Russia: Observational Study of Effectiveness and Return on Investment for the Employer pp. 89-99

O. At'kov,, A.V. Azarov, D.A. Zhukov, N. Nicoloyannis and L. Durand

Influence of Patient Co-Payments on Atypical Antipsychotic Choice in Poland: Implications Once Generic Atypicals are Available pp. 101-110

Magda Wladysiuk, Aleksander Araszkiewicz, Brian Godman, Katarzyna Szabert, Corrado Barbui and Alan Haycox

Current and Future Economic Burden of Osteoporosis in New Zealand pp. 111-123

Paul Brown, Rob McNeill, William Leung, Eman Radwan and Jane Willingale

Impact of Fibromyalgia Severity on Health Economic Costs: Results from a European Cross-Sectional Study pp. 125-136

Andreas Winkelmann, Serge Perrot, Caroline Schaefer, Kellie Ryan, Arthi Chandran, Alesia Sadosky and Gergana Zlateva

Volume 9, issue 1, 2011

The Chinese Healthcare System: Structure, Problems and Challenges pp. 1-13

Jens Leth Hougaard, Lars Østerdal and Yi Yu

Valuing Child Health Utility 9D Health States with a Young Adolescent Sample: A Feasibility Study to Compare Best-Worst Scaling Discrete-Choice Experiment, Standard Gamble and Time Trade-Off Methods pp. 15-27

Julie Ratcliffe, Leah Couzner, Terry Flynn, Michael Sawyer, Katherine Stevens, John Brazier and Leonie Burgess

Costs to Hospitals of Acquiring and Processing Blood in the US: A Survey of Hospital-Based Blood Banks and Transfusion Services pp. 29-37

Richard Toner, Laura Pizzi, Brian Leas, Samir Ballas, Alyson Quigley and Neil Goldfarb

Determinants of Out-of-Pocket Health Expenditure in China: Analysis Using China Health and Nutrition Survey Data pp. 39-49

Xuedan You and Yasuki Kobayashi

The Impact of CT Colonography for Colorectal Cancer Screening on the UK NHS: Costs, Healthcare Resources and Health Outcomes pp. 51-64

Alison Sweet, David Lee, Kerry Gairy, Denver Phiri, Timothy Reason and Kevin Lock